TY - JOUR
T1 - Protein pathway activation mapping of colorectal metastatic progression reveals metastasis-specific network alterations
AU - Silvestri, Alessandra
AU - Calvert, Valerie
AU - Belluco, Claudio
AU - Lipsky, Michael
AU - De Maria Marchiano, Ruggero
AU - Deng, Jianghong
AU - Colombatti, Alfonso
AU - De Marchi, Francesco
AU - Nitti, Donato
AU - Mammano, Enzo
AU - Liotta, Lance
AU - Petricoin, Emanuel
AU - Pierobon, Mariaelena
PY - 2012
Y1 - 2012
N2 - The mechanism by which tissue microecology influences invasion and metastasis is largely unknown. Recent studies have indicated differences in the molecular architecture of the metastatic lesion compared to the primary tumor, however, systemic analysis of the alterations within the activated protein signaling network has not been described. Using laser capture microdissection, protein microarray technology, and a unique specimen collection of 34 matched primary colorectal cancers (CRC) and synchronous hepatic metastasis, the quantitative measurement of the total and activated/phosphorylated levels of 86 key signaling proteins was performed. Activation of the EGFR–PDGFR-cKIT network, in addition to PI3K/AKT pathway, was found uniquely activated in the hepatic metastatic lesions compared to the matched primary tumors. If validated in larger study sets, these findings may have potential clinical relevance since many of these activated signaling proteins are current targets for molecularly targeted therapeutics. Thus, these findings could lead to liver metastasis specific molecular therapies for CRC.
AB - The mechanism by which tissue microecology influences invasion and metastasis is largely unknown. Recent studies have indicated differences in the molecular architecture of the metastatic lesion compared to the primary tumor, however, systemic analysis of the alterations within the activated protein signaling network has not been described. Using laser capture microdissection, protein microarray technology, and a unique specimen collection of 34 matched primary colorectal cancers (CRC) and synchronous hepatic metastasis, the quantitative measurement of the total and activated/phosphorylated levels of 86 key signaling proteins was performed. Activation of the EGFR–PDGFR-cKIT network, in addition to PI3K/AKT pathway, was found uniquely activated in the hepatic metastatic lesions compared to the matched primary tumors. If validated in larger study sets, these findings may have potential clinical relevance since many of these activated signaling proteins are current targets for molecularly targeted therapeutics. Thus, these findings could lead to liver metastasis specific molecular therapies for CRC.
KW - Colorectal cancer
KW - Metastasis
KW - Protein pathway activation mapping
KW - Proteomics
KW - Reverse phase protein microarray
KW - Tumor microenvironment
KW - Colorectal cancer
KW - Metastasis
KW - Protein pathway activation mapping
KW - Proteomics
KW - Reverse phase protein microarray
KW - Tumor microenvironment
UR - http://hdl.handle.net/10807/111517
U2 - 10.1007/s10585-012-9538-5
DO - 10.1007/s10585-012-9538-5
M3 - Article
SN - 0262-0898
SP - 309
EP - 316
JO - CLINICAL & EXPERIMENTAL METASTASIS
JF - CLINICAL & EXPERIMENTAL METASTASIS
ER -